title: Cooperation between Shh and IGF-I in promoting myogenic proliferation and differentiation via the MAPK/ERK and PI3K/Akt pathways requires Smo activity.
abstract: Sonic Hedgehog (Shh) has been shown to promote adult myoblast proliferation and differentiation and affect Akt phosphorylation via its effector Smoothened (Smo). Here, the relationship between Shh and insulin-like growth factor I (IGF-I) was examined with regard to myogenic differentiation via signaling pathways which regulate this process. Each factor enhanced Akt and MAPK/ERK (p42/44) phosphorylation and myogenic factor expression levels in a dose-responsive manner, while combinations of Shh and IGF-I showed additive effects. Blockage of the IGF-I effects by neutralizing antibody partially reduced Shh's effects on signaling pathways, suggesting that IGF-I enhances, but is not essential for Shh effects. Addition of cyclopamine, a Smo inhibitor, reduced Shh- and IGF-I-induced Akt phosphorylation in a similar manner, implying that Shh affects gain of the IGF-I signaling pathway. This implication was also examined via a genetic approach. In cultures derived from Smo(mut) (MCre;Smo(flox/flox)) mice lacking Smo expression specifically in hindlimb muscles, IGF-I-induced Akt and p42/44 phosphorylation was significantly reduced compared to IGF-I's effect on Smo(cont) cells. Moreover, remarkable inhibition of the stimulatory effect of IGF-I on myogenic differentiation was observed in Smo(mut) cultures, implying that intact Smo is required for IGF-I effects in myoblasts. Immunoprecipitation assays revealed that tyrosine-phosphorylated proteins, including the regulatory unit of PI3K (p85), are recruited to Smo in response to Shh. Moreover, IGF-IR was found to associate with Smo in response to Shh and to IGF-I, suggesting that Shh and IGF-I are already integrated at the receptor level, a mechanism by which their signaling pathways interact in augmenting their effects on adult myoblasts.
authors: Department of Animal Sciences, The Hebrew University of Jerusalem, Rehovot, Israel.
authors: D
authors: D
authors: Madhala-Levy
authors: V C
authors: VC
authors: Williams
authors: S M
authors: SM
authors: Hughes
authors: R
authors: R
authors: Reshef
authors: O
authors: O
authors: Halevy
references: Biochim Biophys Acta. 1999 Jan 11;1448(3):372-80
references: 9990289
references: Dev Biol. 2011 Feb 15;350(2):464-75
references: 21147088
references: Biochim Biophys Acta. 2007 Sep;1773(9):1438-46
references: 17688959
references: Nat Rev Genet. 2006 Nov;7(11):841-50
references: 17047684
references: Development. 2009 Feb;136(3):403-14
references: 19141670
references: Pharmacol Rev. 2010 Sep;62(3):497-524
references: 20716670
references: Exp Cell Res. 2004 Jul 1;297(1):224-34
references: 15194438
references: J Cell Sci. 2009 Aug 1;122(Pt 15):2760-8
references: 19596798
references: Dev Dyn. 2004 Nov;231(3):489-502
references: 15390217
references: Curr Med Chem. 2005;12(24):2881-91
references: 16305477
references: Genes Dev. 1995 Dec 1;9(23):2911-22
references: 7498788
references: Mol Cell Biol. 1995 Apr;15(4):2294-303
references: 7891723
references: J Biol Chem. 1997 Mar 7;272(10):6653-62
references: 9045696
references: Int J Dev Biol. 2002;46(7):905-14
references: 12455628
references: J Appl Physiol (1985). 2009 Jan;106(1):233-40
references: 19023019
references: Nature. 1977 Dec 22-29;270(5639):725-7
references: 563524
references: Development. 2001 Mar;128(5):743-52
references: 11171399
references: Development. 2008 Oct;135(19):3291-300
references: 18755774
references: Genesis. 2005 Apr;41(4):202-9
references: 15789408
references: Dev Cell. 2002 Sep;3(3):397-409
references: 12361602
references: Development. 1999 Sep;126(18):4053-63
references: 10457014
references: Nature. 2005 Jun 16;435(7044):954-8
references: 15843802
references: J Cell Biol. 2004 Aug 2;166(3):347-57
references: 15277541
references: Dev Biol. 2000 Aug 15;224(2):189-203
references: 10926759
references: Nat Cell Biol. 2001 Nov;3(11):1009-13
references: 11715022
references: BMC Dev Biol. 2004 Jul 06;4:9
references: 15238161
references: Nature. 2005 Jun 16;435(7044):948-53
references: 15843801
references: Development. 2001 Dec;128(24):5099-108
references: 11748145
references: Circulation. 2003 Jul 29;108(4):479-85
references: 12860919
references: Curr Opin Cell Biol. 1999 Dec;11(6):683-8
references: 10600704
references: Cancer Res. 2009 Feb 15;69(4):1284-92
references: 19190345
references: Cell Mol Life Sci. 2005 Aug;62(16):1863-70
references: 16003493
references: Endocr Rev. 1996 Oct;17(5):481-517
references: 8897022
references: Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2077-81
references: 10051597
references: J Biol Chem. 2007 Mar 23;282(12):8959-68
references: 17200122
references: Science. 2007 Jul 20;317(5836):372-6
references: 17641202
references: Nature. 2005 Oct 13;437(7061):1018-21
references: 16136078
references: BMC Dev Biol. 2001;1:4
references: 11299042
references: Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4505-10
references: 16537363
references: J Cell Biol. 2002 Feb 18;156(4):751-60
references: 11839766
references: Nat Rev Mol Cell Biol. 2005 Apr;6(4):306-17
references: 15803137
references: Nat Genet. 2004 Jan;36(1):88-93
references: 14702044
references: Development. 1998 Feb;125(3):495-505
references: 9425144
references: Genes Dev. 1997 Sep 1;11(17):2163-75
references: 9303533
references: Science. 2004 Jun 18;304(5678):1755-9
references: 15205520
references: Biochim Biophys Acta. 2009 May;1793(5):755-63
references: 19211028
references: Curr Opin Pharmacol. 2008 Jun;8(3):352-7
references: 18353722
references: Proc Natl Acad Sci U S A. 2006 May 30;103(22):8408-13
references: 16707575
references: Genes Dev. 2001 Dec 1;15(23):3059-87
references: 11731473